Panchang ~ Manmohan Singh ~ Sonia Gandhi ~ Stock Markets ~ Gossip
Home / India News / 2003 / August / The Indian Pharmaceutical Industry - A Perspective
Related Information
Global Pharma Business Convention to be held in Mumbai

Task Force decides to strengthen Indian systems of medicine

Indigenous Pharmaceuticals

Exemption of Drugs from Price Control

Revision of Prices of Bulk Drugs Betamethasone & its Derivatives & IBUPROFEN
August 23 in History

Events and happenings on 23 August in History

23 August 2001
Highlights: Hamsa Awards for 2001 announced

23 August 2002
Highlights: Venkiah Naidu visits Visakhapatnam

23 August 2003
Highlights: Special tribunal for River Krishna

23 August 2004
Highlights: TRS Minister warns of strike

23 August 2005

23 August 2006
Highlights: Congres never cheated TRS

23 August 2007
Highlights: State Government offers to set up a monitoring committee

Top News

The Indian Pharmaceutical Industry - A Perspective
Hyderabad: August 23, 2003

The last 50 years have seen an impressive growth of the pharmaceutical industry in India. Today, the country is the 4th largest manufacturer of pharmaceuticals worldwide.

From a production of mere Rs 180 million of bulk drugs in the 60’s, it has grown to Rs 54.4 billion. This accounts 300 times growth. Formulations have grown almost 140 times from Rs 1500 million to Rs 210 billion and exports from a modest of Rs 30 million to Rs 100 billion.

From a closed, highly controlled environment, the industry has moved towards greater liberlization and is now gearing up to meet the challenges of the WTO regime. India now has the highest number of manufacturing units with about 30 US FDA & 100 TGA/MCA approved facilities plus about 200 WHO GMP approved facilities. A sizeable number of companies have also accelerated their investments in R&D.

The Pharmaceutical industry in India has abundant scientific and technical manpower, thus possessing a strong intellectual capital. It is ideally suited for conducting clinical research in view of its genetic diversity. It has a rich heritage of herbal products too, along with a plethora of APIs, intermediates, chemicals and excipients. No wonder therefore, McKinsey & Company has forecasted a compounded growth of 19 per cent for the Indian Pharmaceutical Industry.

Press Release by: Solus Media
Clickz..

Asuku.com
Talk about Everything and Anything...

AndhraNews.com
The Andhra Pradesh Discussion Forum

ElectionsInfo.com
Coverage on Elections round the World